COVID-19 and Hartnup disease: an affair of intestinal amino acid malabsorption
- 20 July 2020
- journal article
- research article
- Published by Springer Nature in Eating and Weight Disorders - Studies on Anorexia, Bulimia and Obesity
- Vol. 26 (5) , 1647-1651
Abstract
Since the outbreak of COVID-19, clinicians have tried every effort to fight the disease, and multiple drugs have been proposed. However, no proven effective therapies currently exist, and different clinical phenotypes complicate the situation. In clinical practice, many severe or critically ill COVID-19 patients developed gastrointestinal (GI) disturbances, including vomiting, diarrhoea, or abdominal pain, even in the absence of cough and dyspnea. Understanding the mechanism of GI disturbances is warranted for exploring better clinical care for COVID-19 patients. With evidence collected from clinical studies on COVID-19 and basic research on a rare genetic disease (i.e., Hartnup disorder), we put forward a novel hypothesis to elaborate an effective nutritional therapy. We hypothesize that SARS-CoV-2 spike protein, binding to intestinal angiotensin-converting enzyme 2, negatively regulates the absorption of neutral amino acids, and this could explain not only the GI, but also systemic disturbances in COVID-19. Amino acid supplements could be recommended. Level of evidence No level of evidence: Hypothesis article.Keywords
Funding Information
- Fondazione Cariplo (1006-2016)
This publication has 24 references indexed in Scilit:
- ACE2 – From the renin–angiotensin system to gut microbiota and malnutritionMicrobes and Infection, 2013
- Branched-Chain Amino Acid Supplementation Promotes Survival and Supports Cardiac and Skeletal Muscle Mitochondrial Biogenesis in Middle-Aged MiceCell Metabolism, 2010
- Tissue-Specific Amino Acid Transporter Partners ACE2 and Collectrin Differentially Interact With Hartnup MutationsGastroenterology, 2009
- Essential role for collectrin in renal amino acid transportNature, 2006
- A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus–induced lung injuryNature Medicine, 2005
- Angiotensin-converting enzyme 2 protects from severe acute lung failureNature, 2005
- Hartnup disorder is caused by mutations in the gene encoding the neutral amino acid transporter SLC6A19Nature Genetics, 2004
- Mutations in SLC6A19, encoding B0AT1, cause Hartnup disorderNature Genetics, 2004
- Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirusNature, 2003
- Collectrin, a Collecting Duct-specific Transmembrane Glycoprotein, Is a Novel Homolog of ACE2 and Is Developmentally Regulated in Embryonic KidneysJournal of Biological Chemistry, 2001